Maxlinear (MXL) Cash & Equivalents (2010 - 2026)

Maxlinear (MXL) has reported Cash & Equivalents for 17 consecutive years, with $64.8 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Cash & Equivalents fell 40.33% year-over-year to $64.8 million in Q2 2026; TTM through Jun 2026 was $64.8 million, a 40.33% decrease from a year earlier, with the FY2025 full-year figure at $72.8 million, down 38.6% from the prior year.
• Cash & Equivalents was $64.8 million for Q2 2026 at Maxlinear, up from $61.1 million in the prior quarter.
• Over five years, Cash & Equivalents peaked at $224.6 million in Q2 2023 and troughed at $61.1 million in Q1 2026.
• A 5-year average of $150.2 million and a median of $166.3 million in 2022 frame the typical range for Cash & Equivalents.
• Across the five-year window, Cash & Equivalents soared 62.2% in 2022 and tumbled 46.44% in 2025, its largest moves.
• Over 5 years, Cash & Equivalents stood at $187.4 million in 2022, then retreated by 0.03% to $187.3 million in 2023, then plunged by 36.69% to $118.6 million in 2024, then tumbled by 38.6% to $72.8 million in 2025, then fell by 10.98% to $64.8 million in 2026.
• The last three Cash & Equivalents figures came in at $64.8 million (Q2 2026), $61.1 million (Q1 2026), and $72.8 million (Q4 2025), per Business Quant data.